Department of Molecular, Cellular and Biomedical Sciences University of New Hampshire, Durham, NH, United States.
Biotherapeutics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States.
Front Immunol. 2024 Oct 15;15:1437516. doi: 10.3389/fimmu.2024.1437516. eCollection 2024.
The specificity of cytokine and immunoreceptor signaling frequently depends upon receptor recruitment of select adaptor proteins and specifically engaged effectors. This review focuses on the orthologous adaptor proteins, HGAL and C1ORF150, and aims to provide insight into their respective modulation of lymphoid and myeloid cell signaling, formation, and function. HGAL acts predominantly within germinal center B cells as an important BCR signal transducer. Effects on BCR signalosome assembly involve HGAL's localization to the plasma membrane via its lipidation, initial interactions with SYK, the pY-phosphorylation of HGAL including its recruitment of GRB2, and HGAL engagement of PDZ-RhoGEF and RhoA signaling. At ligated BCRs, this includes HGAL(-GRB2) stimulation of SYK kinase, attenuation of calcium flux-dependent and NF-κB expression, promotion of cSMAC formation, and cytoskeletal remodeling associated with HGAL-attenuated cell migration. HGAL and partnered effectors also impact on DLBCL pathogenesis, and studies are summarized on HGAL's actions (using DLBCL and Burkitt lymphoma B cells) including cell migration effects, HGAL modulation of cytoskeletal components, and insightful HGAL transgenic mouse and xenograft models. For C1ORF150, its HGAL-homologous subdomains are considered, together with studies that demonstrate C1OR150's FcϵRI- and KIT-mediated expression and phosphorylation in primary human mast cells. Intriguingly, recent GWAS studies have identified a in-frame splice variant that is strongly associated with urticaria. Candidate mechanisms via which the encoded "C1ORF150-Δexon2" isoform affects mast cell degranulation are considered, including FcϵR1 and/or KIT receptor connections, and candidate "myristoylation switch" mechanisms.
细胞因子和免疫受体信号的特异性通常取决于受体对特定衔接蛋白的募集和特定效应物的参与。本篇综述重点关注同源衔接蛋白 HGAL 和 C1ORF150,并旨在深入了解它们各自对淋巴样和髓样细胞信号转导、形成和功能的调节作用。HGAL 主要作为 BCR 重要信号转导子在生发中心 B 细胞中发挥作用。对 BCR 信号小体组装的影响涉及 HGAL 通过其脂质化定位到质膜,与 SYK 的初始相互作用、HGAL 的 pY 磷酸化,包括其招募 GRB2,以及 HGAL 与 PDZ-RhoGEF 和 RhoA 信号的结合。在连接的 BCR 上,这包括 HGAL(-GRB2)对 SYK 激酶的刺激、钙通量依赖性和 NF-κB 表达的衰减、促进 cSMAC 形成以及与 HGAL 减弱的细胞迁移相关的细胞骨架重塑。HGAL 和合作伙伴效应物也影响 DLBCL 的发病机制,综述了 HGAL 在包括细胞迁移效应、HGAL 对细胞骨架成分的调节以及有见地的 HGAL 转基因小鼠和异种移植模型中的作用的研究。对于 C1ORF150,考虑了其与 HGAL 同源的亚结构域,以及证明 C1OR150 在原代人肥大细胞中 FcϵRI 和 KIT 介导的表达和磷酸化的研究。有趣的是,最近的 GWAS 研究鉴定出一个与荨麻疹强烈相关的内含子剪接变异体。考虑了该编码的“C1ORF150-Δexon2”同工型通过哪些候选机制影响肥大细胞脱粒,包括 FcϵR1 和/或 KIT 受体连接,以及候选的“豆蔻酰化开关”机制。